Shots:

• Cipla expands partnership with Roche to improve access to key oncology medicines which include Herclon (trastuzumab)- Avastin (bevacizumab) and Ristova (rituximab) in India. Cipla will be responsible for the marketing and distribution of Roche’s key products
• In Feb’2018- the two companies collaborated for the promotion and distribution of Actemra (tocilizumab) and other products
•  The collaboration will focus on providing Roche innovations in India while the Roche will keep on collaborating with the relevant stakeholders in the Indian healthcare system to ensure better outcomes for patients

Click here to read full press release/ article 

Ref: Cipla | Image: Roche